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Epigenetic regulation of Calcrl in chemotherapy-induced peripheral neuropathy. 
(in preparation)  
  
 - iv - 
TABLE OF CONTENTS 
List of Abbreviations ................................................................................................................... vi 
Abstract .......................................................................................................................................... 1 
Chapter 1: Introduction ................................................................................................................ 1 
Definitions of Epigenetics ............................................................................................................ 2 
Chromatin Structure and Function .............................................................................................. 3 
Modeling Neuropsychiatric Conditions in Rodents ..................................................................... 5 
Linking Epigenetics with Molecular Psychiatry ........................................................................... 7 
Prepulse Inhibition: A Behavioral Model of Sensorimotor Gating .............................................. 9 
Table 1. Examples of ‘Gating’ Disorders .................................................................................. 10 
Monoamine Neurotransmitter Receptors in Sensorimotor Gating ........................................... 10 
Studying Epigenetics by Chromatin Immunoprecipitation Assay of Histone PTMs ................. 12 
Chapter 2: Materials and Methods ............................................................................................ 13 
Animals ...................................................................................................................................... 13 
Prepulse Inhibition (PPI) of Acoustic Startle Reflex ................................................................. 13 
mRNA Extraction and Purification............................................................................................. 14 
qPCR Analysis of mRNA Expression ....................................................................................... 15 
Western Blotting ........................................................................................................................ 15 
Chromatin Crosslinking ............................................................................................................. 16 
Optimization of Chromatin Solubilization and Fragmentation .................................................. 17 
Chromatin Immunoprecipitation Assay ..................................................................................... 18 
Precipitation of Immunoprecipitated gDNA Fragments ............................................................ 19 
qPCR Analysis of Chromatin Immunoprecipitated Genomic DNA (ChIP-qPCR) .................... 19 
Statistical Methods .................................................................................................................... 20 
Chapter 3: Results ...................................................................................................................... 21 
Segregation of NIH-HS Rats Into Groups by PPI Response ................................................... 21 
Increased mRNA Expression in Low PPI Group ...................................................................... 21 
Regression Analysis of Gene Expression & PPI Response ..................................................... 21 
Adaptation of Chromatin Immunoprecipitation Assay .............................................................. 22 
Chromatin IP of H3ac and H3K27me3 Marks in High and Low PPI Animals .......................... 24 
Chapter 4: Figures ...................................................................................................................... 25 
Figure 1. Chromatin’s Structural and Functional Unit Is The Nucleosome .............................. 25 
Figure 2. Segregation of NIH-HS Rats into Different PPI Groups ............................................ 26 
Figure 3. mRNA Expression in Low and High PPI Groups ...................................................... 27 
Figure 4. Regression Analysis Between PPI Response and mRNA Expression .................... 28 
Figure 5. Chromatin Immunoprecipitation Protocol .................................................................. 29 
Figure 6. Pilot Studies of ChIP Technical Parameters ............................................................. 30 
Figure 7. H3ac and H3K27me3 Levels at Gapdh Promoter ..................................................... 31 
Figure 8. H3ac and H3K27me3 Levels at Regions of Grm2 in Frontal Cortex ........................ 32 
Figure 9. H3ac and H3K27me3 Levels at Regions of Drd2 in Striatum ................................... 33 
Figure 10. H3ac Levels at Regions of Genes in Frontal Cortex ............................................... 34 
Figure 11. H3K27me3 Levels at Regions of Genes in Frontal Cortex ..................................... 35 
Chapter 5. Discussion ................................................................................................................ 36 
Feasibility of Chromatin Immunoprecipitation in Frozen Brain Tissue ..................................... 36 
 - v - 
Epigenetic Alterations in Synaptic Plasticity Genes ................................................................. 38 
Appendix ...................................................................................................................................... 42 
Table 2. RT-qPCR Oligonucleotide Sequences (Rattus norvegicus) ...................................... 42 
Table 3. Recommended Thermocycle Profiles for RT-qPCR .................................................. 42 
Table 4. ChIP-qPCR Oligonucleotide Sequences (Rattus norvegicus) ................................... 43 
Table 5. Column Statistics of PPI Response of PPI Groups .................................................... 44 
Table 6. PPI Response of PPI Groups to Different Prepulse Intensities ................................. 44 
Table 7. Multinomial Logistic Regression Analysis Of PPI Response & mRNA Levels .......... 44 
Table 8. Multiple t Tests with Holm-Šidák’s Multiple Corrections: Gene Expression .............. 45 
Table 9. Mann-Whitney Tests of H3ac and H3K27me3 ChIP (Gapdh Promoter) ................... 45 
Table 10. Two-way ANOVA of H3ac and H3K27me3 ChIP in Frontal Cortex ......................... 45 
Table 11. Two-way ANOVA of H3ac and H3K27me3 ChIP in Striatum (Drd2) ....................... 46 
References ................................................................................................................................... 47 
 
  
 - vi - 
LIST OF ABBREVIATIONS 
PPI Prepulse inhibition of the acoustic startle response 
ChIP Chromatin immunoprecipitation 
qPCR Quantitative polymerase chain reaction 
CNS Central nervous system 
Grm2 Metabotropic glutamate receptor subtype 2 
Htr1a 5-Hydroxytryptamine (serotonin) receptor 1A 
Htr2a  5-Hydroxytryptamine (serotonin) receptor 2A 
Drd1 Dopamine receptor D1 
Drd2 Dopamine receptor D2 
Gapdh Glyceraldehyde 3-phosphate dehydrogenase 
NMDA N-methyl-D-aspartate 
PCP Phencyclidine 
H3ac Pan-acetylated histone H3 
H3K27me3 Trimethylation of lysine residue 27 of histone H3 
RHA Roman high avoidance 
RLA Roman low avoidance 
NIH-HS National Institute of Health Heterogenous Stock 
gDNA Genomic DNA 
HDAC Histone deacetylase 
s.e.m. Standard error of the mean 
bps Base pairs 
 - 1 - 
ABSTRACT 
Sensorimotor gating impairments are observed across a range of neuropsychiatric 
conditions. The prepulse inhibition of the acoustic startle response (PPI) is a validated measure 
of sensorimotor gating. Genetic and pharmacological manipulations in rodents have shown PPI 
is regulated by specific brain monoaminergic systems. Using genetically heterogeneous NIH-HS 
rats, we stratified individuals by %PPI. In low PPI animals, we observed elevated mRNA levels of 
certain neurotransmitter receptors, including metabotropic glutamate receptor Grm2, dopamine 
receptors Drd1 and Drd2, serotonin receptors Htr1a and Htr2a, and scaffolding protein Homer1, 
in the frontal cortex (FC) and striatum (STR). We found Drd2 mRNA levels were significantly 
increased in the low PPI group in STR. Multinomial regression analysis indicated Grm2 in FC and 
Grm2 and Drd2 in STR predicted PPI group. Additional studies showed a linear relationship 
between PPI and Grm2 in FC and Drd2 in STR. To explore possible epigenetic regulation of 
altered gene transcription, we adapted chromatin immunoprecipitation (ChIP) for novel 
application in frozen brain tissue. We evaluated abundance of acetylated histone H3 (H3ac) and 
trimethylation of lysine residue 27 of histone H3 (H3K27me3) at regions upstream of gene 
transcription start sites. No differences in levels of H3ac or H3K27me3 were observed. Studies 
assessing abundance of other histone modifications are warranted. These efforts may offer 
insight on how epigenetic modification leads to altered transcription of synaptic plasticity genes 
regulating sensorimotor gating observed in neuropsychiatric conditions. 
CHAPTER 1: INTRODUCTION 
At the 7th World Congress of Psychiatric Genetics, those dedicated to understanding 
molecular mechanisms of the mind were met with a puzzle. In psychotic disorders like 
schizophrenia, there was a high degree of discordance in twin and family studies (DeLisi et al., 
2000, 2000; Kendler and Diehl, 1993). If genes determine phenotype, what could be playing a 
role in psychiatric traits not predicted by rules of Mendelian inheritance? Faced with these facts, 
genes it seemed were more dispositional than dispositive in disease processes, and conferees 
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broached the idea of epigenetics to offer some explanation in schizophrenia and other related 
disorders (Petronis et al., 2000). Toward the turn of the century, the field of epigenetics has 
emerged to address this puzzle, providing yet more insight into the etiology of human diseases. 
The polygenic and multifactorial nature of neuropsychiatric disorders underscores the importance 
of investigations into epigenetic mechanisms which may reconcile the dual influence of genes 
and environment. This study in heterogeneous stock (HS) rats aims to characterize patterns of 
histone modifications at genes regulating sensorimotor gating. Locus-specific alterations in 
histone modification could provide important insights into epigenetic mechanisms governing 
transcriptional regulation in neuropsychiatric disorders.  
DEFINITIONS OF EPIGENETICS 
Epigenetics is not a novel paradigm yet it aims to revise the central dogma of molecular 
biology. The term ‘epigenetics’ was borrowed from the field of embryology, used to refer to the 
developmental theory of epigenesis (Waddington, 1942). Epigenesis proposed the notion that 
organisms could ultimately trace their origins to a progenitor cell, entirely undifferentiated 
(Holliday, 1994). The competing theory of preformation on the other hand staked the claim that 
within germ cells lay tiny, prototypical embryos. With time, technology, and the discovery of genes, 
notion of preformation was debunked, as molecular biology firmly demonstrated that DNA and its 
molecular intermediaries were determinative in the developmental fate of cells, and thus of the 
organism. In the second half of the twentieth century, as scientific minds sought to connect genes 
to disease aided by yet finer DNA biotechnologies, the field of genetics came to the fore, while 
epigenetics, as originally conceptualized, was relegated to the realm of niche research. 
In its broadest operational definition, epigenetics can be defined as various phenotypic 
interpretations of a single genome sequence. In other words, epigenetics describes a 
phenomenon, literally “above the genes,” that allows for the panoply of cellular phenotypes from 
one original blueprint within a single cell without changing individual A, T, G, or G nucleotides. 
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What are the molecular mediators that determine cell fate, that allow certain genes to be 
expressed and others repressed?  
Several areas of epigenetics, including DNA methylation, histone posttranslational 
modification (PTM), and microRNAs, can serve to regulate gene expression (Cedar and Bergman, 
2009; Grewal and Moazed, 2003; Henikoff and Shilatifard, 2011; Strahl and Allis, 2000). Perhaps 
the best-known epigenetic alteration is DNA methylation that occur within CpG islands. DNA 
methylation is thought to be involved in the spatiotemporal control of gene expression during 
development. Its misregulation is commonly observed in cancer, where promoter 
hypermethylation silences tumor suppressor genes to promote malignant transformation. CpG 
island methylation plays an important role in transcriptional regulation, and it is commonly altered 
during malignant transformation (Baylin and Jones, 2011; Dawson and Kouzarides, 2012; Sproul 
and Meehan, 2013). The functional relevance of these regional alterations in methylation are yet 
to be fully deciphered, but it is interesting to note that they have challenged the general dogma 
that DNA methylation invariably equates with transcriptional silencing. Another growing subfield 
of epigenetics includes microRNA-mediated gene downregulation. Just twenty-two nucleotides in 
length, these small RNA species negatively regulate target gene expression via a 
posttranscriptional mechanism called RNAi or RNA interference. RNAi is naturally triggered in the 
presence of double-stranded RNA of viruses and constitutes a defense mechanism in eukaryotes. 
microRNAs exert their effect of gene silencing when they bind cognate mRNA via sequence 
complementarity, thus targeting the mRNA for enzymatic degradation.  
CHROMATIN STRUCTURE AND FUNCTION 
Chromatin reflects the strategy that nature evolved to fit the genome within the nucleus, 
some 6 microns in diameter (Figure 1). Its most basic unit is the nucleosome particle, around 
which a length of 147 DNA base-pairs (bp) are coiled. The nucleosome core is octameric, 
consisting of two copies of each of the four core histone proteins (H2A, H2B, H3 and H4). The 
octamer assembles when a tetramer of two H3 and H4 complexes with two H2A/H2B dimers 
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(Andrews and Luger, 2011; Luger et al., 1997), and this assembly in turn binds approximately 
three billion DNA base pairs around about 30 million nucleosomes in humans. This effectively 
reduces DNA length from 2 meters to the so-called ‘beads on a string’ model, with each bead 
representing one nucleosome, as first depicted by electron microscopists. Additional higher-order 
folding ultimately results in the textbook X-shaped structure commonly known as a chromosome, 
and when viewed as a whole after Giemsa staining, distinct bands can be discerned, chromatin 
can be loosely or tightly structured, termed euchromatin or heterochromatin, respectively.  
Beyond a role in DNA compaction, chromatin actively participates in the regulation of DNA 
replication, repair, and transcription. Studies have observed a range of altered transcriptional 
outcomes when chromatin state is altered locally, such as reorganization of nucleosome density, 
or globally, as seen in gene silencing via heterochromatinization. Each nucleosome particle 
contains eight histone monomers that have solvent-exposed N-terminal tails subject to covalent 
post-translational modifications (PTMs) by enzymatic complexes. There is a growing number of 
histone PTMs, including methylation, acetylation, phosphorylation, ubiquitination, ADP 
ribosylation, SUMOylation, crotonylation, citrullination, among others. 
Several mechanisms have been described to explain how histone PTMs can influence 
gene expression. The charge neutralization model posits that certain PTMs result in structural 
changes to the DNA-histone complex. Electrostatic repulsions between negatively charged 
PTMs, such as acetylation (CH3COO–) or phosphorylation (OPO33-) on adjacent nucleosomes, 
leads to an open conformation of chromatin (Bannister and Kouzarides, 2011). This model 
however fails to explain histone methylation which can be associated with transcriptional 
activation or repression depending on the amino acid residue modified. In the signaling network 
model, the presence of histone PTMs signals for recruitment of additional effector proteins 
(Schreiber and Bernstein, 2002), such as chromatin modifiers, nucleosome remodelers, and/or 
transcription factors that may subsequently act on the chromatin template. Last, the histone code 
hypothesis proposes that certain patterns of histone PTMs are interpreted by effectors, either in 
 - 5 - 
sequence or in tandem, to specify unique outcomes (Strahl and Allis, 2000). Efforts to decipher 
the ‘histone code’ and their effect on gene transcription in healthy and pathological contexts have 
provided some clues (Kouzarides, 2007; Tan et al., 2011).  
Many lysine residues on histone tails, including H3K4, H3K9, H3K27, H3K36, H3K79, and 
H4K20, can be methylated. Methylation of H3K4, H3K36, and H3K79 residues are associated 
with active transcription in euchromatic gene regions, while H3K9, H3K27, and H4K20 
methylation is associated with silenced genes within heterochromatin (Barski et al., 2007). Lysine 
residues moreover may be mono-, di-, or trimethylated, and interesting patterns for the valence 
of histone lysine methylation have been observed to localize within certain upstream regulatory 
gene regions. For instance, H3K4me3 spans the transcriptional start site (TSS) of active genes  , 
H3K4me1 is associated with active enhancers (Heintzman et al., 2009), and H3K4me2 seems to 
demarcate regions of transcription factor binding. Likewise, H3K9me1 may be seen at 
transcriptionally active genes, while H3K9me3 and H3K27me3 are associated with gene 
repression (Barski et al., 2007). What is clear is that histone PTMs are numerous and complex 
and may dynamically convey environmental cues (i.e., drugs of abuse, early life stress) to genes, 
serving to tune their expression resulting in phenotypes beyond what inheritance alone would 
predict.  
MODELING NEUROPSYCHIATRIC CONDITIONS IN RODENTS 
Neuropsychiatric disorders encompass neurological, neurodevelopmental, and 
psychiatric conditions. Together, they are leading causes of disability in the United States, 
accounting for 19% of all years of life lost to disability and premature mortality (The US Burden of 
Disease Collaborators et al., 2018). In any given year, an estimated 18% of US adults suffer from 
mental illness, according to the Center for Behavioral Health Statistics and Quality. Over 50% of 
people in middle- and high-income countries will at some point in their lives come to be afflicted 
as well. The worldwide incidence of those suffering from mental disorders is estimated at 450 
million people, according to the World Health Organization. Neuropsychiatric conditions are of 
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consequence beyond the afflicted individuals. Between 2011 and 2030, the loss of economic 
output from neuropsychiatric conditions is estimated at 16 trillion USD, higher than that of cancer, 
respiratory diseases, and diabetes (Trautmann et al., 2016).  
In the 1980s, linkage studies among family, twin, and adopted cohorts in humans lent 
credence to the notion that genes contribute to psychiatric phenotypes (Gottesman and Carey, 
1983; Kendler and Robinette, 1983; Kessler, 1980; McInnis et al., 1999; Stine et al., 1995). 
Research aimed at identifying genetic factors that predispose individuals to neuropsychiatric 
conditions has been steady since. Biotechnological advances in molecular biology and 
bioinformatics have further strengthened this idea by enabling association studies in yet larger 
cohorts, revealing candidate gene and gene regions. The advent of next generation sequencing 
technology has unveiled genetic factors that have eluded detection by candidate approaches. 
However, identified hundreds or even thousands of genes each contribute less than one percent 
to overall risk of specific disorder (Gratten et al., 2014). Expression profiling in human cerebral 
cortex across five major neuropsychiatric conditions (autism, schizophrenia, bipolar disorder, 
depression, and alcoholism) found patterns of differentially expressed genes unique to each and 
shared across conditions (Gandal et al., 2018). Despite larger data sets and higher-throughput 
screens, mounting studies recapitulate many of the same major findings of earlier works: the 
genetic architecture of major psychiatric disorders is highly polygenic and shares substantial 
etiological overlap. In general, promising study findings have not translated, as psychiatric 
conditions range widely in cause, course, and severity. 
One of the first examples linking genes to addiction was in selective breeding studies of 
rat strains exhibiting differential susceptibility to morphine (Nichols and Hsiao, 1967). Numerous 
studies since have identified genes contributing to addiction of other substances, such as ethanol 
(Gilpin et al., 2008) and methamphetamine (Wheeler et al., 2009), as well as other in psychiatric 
conditions, like mood and anxiety disorders and schizophrenia. Studies in the inbred rat strains 
Roman high avoidance (RHA) and Roman low avoidance (RLA) for instance have been useful to 
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reveal strain-specific behavioral traits, including coping mechanisms in response to stress, 
measures of impulsivity, and PPI. Notably, RHA rats exhibited a higher degree of impulsivity and 
susceptibility to substance abuse, as well as diminished performance on tasks of attention, spatial 
learning, and sensorimotor gating (Oliveras et al., 2015). In addition, RHA rats display an 
enhanced dopaminergic response to drugs of abuse and aversive stimuli within the frontal cortex 
and striatum, followed by elevated cortical serotonin levels (Giorgi et al., 2003). These molecular 
and behavioral observations suggested the RHA strain may serve as a putative model for 
impaired PPI. Compared to inbred rat strains, outbred rodent models like the NIH-HS rat strain 
have also been used. The genetically heterogenous NIH-HS colony was generated at the National 
Institutes of Health from eight inbred founder strains (Hansen & Spuhler, 1984). Since their 
origination in 1984, colonies have been maintained by a pseudorandom breeding scheme aimed 
at maximizing genetic variation. HS animals have been employed to fine-map complex traits 
relevant to conditions ranging from diabetes and heart disease to anxiety and addiction. This 
feature makes the NIH-HS rat model especially useful for investigations of the genetic and 
neurobiological correlates of complex psychiatric traits, like deficits in PPI response.  
LINKING EPIGENETICS WITH MOLECULAR PSYCHIATRY 
Owing the failure to translate promising study findings to therapeutic application, current 
models of neuropsychiatric conditions now emphasize the interaction of environmental and social 
factors across life course, as well as a component of genes. Given the disappointment 
surrounding genome association studies for some neuropsychiatric disorders, focus has turned 
to mechanisms which can mediate changes in gene expression independent of changes to DNA 
sequence, like posttranslational modification of histones. Numerous histone modifications are 
likely involved in regulation of the acquisition and maintenance of neuropathological states, with 
histone acetylation and methylation as the most characterized to date. Changes in histone 
acetylation have offered clues into how the environment can induce broad transcriptomic changes 
by altering the epigenetic landscape via histone PTMs (Borrelli et al., 2008). There is now ample 
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evidence that some measure of the environment plays a role in the progression of 
neuropsychiatric disease (Volkow et al., 2019). Because of the strong influence of external risk 
factors on the likelihood that an individual develops a neuropsychiatric condition, it may be that 
epigenetic mechanisms regulate the early prodromal period and consequently leading to a 
pathophysiological state. Ample studies demonstrate that cocaine regulates histone acetylation 
in rodents (Renthal et al., 2009; Rogge and Wood, 2013). Interestingly, long-term cocaine 
exposure resulted in Hdac5-dependent behavioral sensitization to subsequent doses and to 
stressors, while acute exposure did not (Renthal et al., 2007). This suggested a homeostatic 
balance of histone acetylation regulates saliency of environmental stimuli, disruption of which may 
be involved in the transition from an acute adaptive response to a chronic psychiatric illness like 
drug addiction.  
Studies have also investigated epigenetic regulation of stress resilience by histone 
acetylation in rodents. One study showed that rats selectively bred on the basis of their high 
novelty-induced motor activity (high-responders) were subjected to environmental stress and their 
preference for sucrose solution was measured (Hollis et al., 2011). High-responders post-stress 
exhibited less sucrose preference compared to low-responders, a change that was mirrored in 
levels of acetylated histone H3 and H2B within the hippocampus.  
Histone methylation also dynamically alters chromatin state underlying pathophysiological 
responses to stress, as well as to psychotropic drug treatments, in rodents. Another study found 
that social or isolation stress resulted in widespread alterations in methylation of H3K27 levels at 
the upstream regulatory regions across a wide swath of genes, among which are involved in 
transcriptional regulation themselves (Wilkinson et al., 2009). In the rat/mouse hippocampus 
following chronic social defeat stress, BDNF levels are diminished concurrent with repressive 
histone modifications. Notably, antidepressant treatment was found to upregulate BDNF 
expression via histone acetylation (Tsankova et al., 2006). However in the nucleus accumbens, 
social stress induces a state of hyperacetylation of histone H3 associated with decreased Hdac2, 
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which can be restored by HDAC inhibitors to promote stress resilience (Covington et al., 2009).  
Interestingly, learning and memory has been shown to be regulated in part by H3K4 methylation, 
dysregulation of which is associated with impaired cognition and intellectual disability (Collins et 
al., 2019). Though studies looking at histone modifications in depressed human post-mortem 
samples are scant, a study of the prefrontal cortex has reported altered levels of histone 
methylation (H3K4me3 and H3K27me3) in promoter regions of BDNF (Chen et al., 2011). 
Together, these findings suggest that epigenetic processes regulate neurophysiological 
processes like synaptic plasticity in rodents via gene transcription and may be leveraged for 
therapeutic intervention in human disease. 
PREPULSE INHIBITION: A BEHAVIORAL MODEL OF SENSORIMOTOR GATING 
A number of neuropsychiatric disorders are linked by impairments in sensorimotor gating, 
an important pre-attentive process of the central nervous system (CNS). Sensorimotor gating 
deficits can be quantified by measuring the prepulse inhibition of the acoustic startle reflex. 
Prepulse inhibition, or PPI, is the suppression of the startle reflex when the intense startling 
stimulus is immediately preceded by a barely detectable prestimulus (Graham, 1975). Ample 
studies support PPI as an operational measure of sensorimotor gating (Swerdlow et al., 2016).  
Deficiencies in sensorimotor gating can cause profound dysfunction in everyday activities 
across a range of diagnostic domains, depending on the nature of the intrusive stimulus whether 
motor, sensory, or cognitive. Evolutionarily, this inhibitory gating process is thought to safeguard 
the integrity of information salient to survive within a complex environment. In healthy individuals, 
sensorimotor gating allows for appropriate behaviors by suppressing or ‘gating’ irrelevant 
exteroceptive or interoceptive stimuli. These so-called ‘gating disorders’ share the criterion of a 
deficiency in inhibitory process within the CNS (Braff et al., 1978, 2001; Mcghie and Chapman, 
1961) and can bridge developmental, psychiatric, and neurological diagnostic domains (Table 1). 
The observation of faulty sensorimotor gating across this wide range underscores the primacy of 
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behavioral inhibition, attention, and selective information processing in generating healthy 
behavioral responses. 
TABLE 1. EXAMPLES OF ‘GATING’ DISORDERS 
Disorder Deficient in gating of… Resulting in… Reference 
Schizophrenia Thoughts, sensory 
stimuli 
Hallucinations, 
impaired cognition, 
psychosis 
(Braff et al., 1978) 
Autism spectrum Thoughts, speech, 
actions 
Stereotypy, 
obsessions 
(McAlonan, 2002) 
Obsessive-
compulsive disorder 
Repetitive, intrusive 
thoughts 
Ritualistic behaviors (Ahmari et al., 2012; 
Swerdlow et al., 1993)  
Tourette’s syndrome Thoughts, speech, 
movements 
Involuntary motor or 
phonic outbursts 
(Castellanos et al., 1996; 
Zebardast et al., 2013) 
Huntington’s 
disease 
Unintentional 
movements 
Adventitious 
movements, chorea 
(Swerdlow et al., 1995; 
Valls-Solé et al., 2004) 
MONOAMINE NEUROTRANSMITTER RECEPTORS IN SENSORIMOTOR GATING 
The PPI paradigm has also proven useful for probing the neurobiological substrates 
underlying sensorimotor gating. The neuroanatomy involved in PPI has been localized within the 
basal forebrain in rodent studies. Lesions of the dorsomedial striatum (Baldan Ramsey et al., 
2011) or infusion of dopamine into the nucleus accumbens impair PPI response (Swerdlow, 
1994). Neural connections that link the limbic cortex with the striatum particularly by the ventral 
striato-pallidal circuitry are believed to modulate the response (Kodsi & Swerdlow, 1996). Based 
on previous studies and on the relevance of the monoamine and glutamate neurotransmitter 
systems as drug targets in neuropsychiatric ‘gating’ disorders, we focused on genes encoding for 
serotonin receptor subtype 1a Htr1a, serotonin receptor subtype 2a Htr2a (Farid, 2000), 
metabotropic glutamate receptor subtype 2 Grm2 (Grauer & Marquis, 1999), dopamine receptor 
type 2 Drd2 (Swerdlow et al., 1990), and the postsynaptic scaffolding protein Homer1. RLA and 
RHA strains exhibit differences in impulsivity, as measured by the 5-choice serial reaction time 
task. RHA animals display enhanced impulsive behavior concomitant with increased serotonin in 
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the striatum and nucleus accumbens, as compared to RLA animals (Moreno et al., 2010). Within 
the frontal cortex of RHA and RLA strains, a pattern of differential binding of highly specific 
radioligands for monoamine receptors Htr1a, Htr2a, and Grm2 has been shown, as well as a 
correlation between Htr2a binding and measures of impulsivity (Klein et al., 2014).  
The receptor pharmacology of certain compounds can also be used to experimentally 
induce sensorimotor gating deficits. For instance, disruption of PPI can result from drugs that 
facilitate dopaminergic activity, such apomorphine (Geyer and Swerdlow, 1998; Martinez et al., 
2000; Swerdlow and Geyer, 1993), amphetamine, or cocaine. Using near-identical stimulus 
parameters between species, the PPI paradigm can also be leveraged to predict efficacy of 
antipsychotic compounds (Swerdlow and Geyer, 1998), and alleviation of apomorphine-mediated 
PPI impairment is correlated with clinical antipsychotic drugs in a potency- and Drd2 dopamine 
receptor affinity-dependent manner (Swerdlow et al., 2006). Serotonin receptors have also been 
shown to mediate the PPI response. Rats given an intracortical infusion of DOI, a Htr2a receptor 
agonist, have increased measures of impulsivity and exhibit pronounced PPI deficits (Sipes and 
Geyer, 1995; Wischhof et al., 2011). Moreover, blockade of Htr2a-mediated intracellular signaling 
attenuates impulsivity-like behaviors induced by cocaine, amphetamine, or MK-801 (O’Neill et al., 
1999). In addition to involvement of brain dopamine and serotonin systems, glutamatergic 
neurotransmitter systems like the N-methyl-D-aspartate (NMDA) receptor have a role in the PPI 
response and sensorimotor gating. Studies using NMDA antagonists, such as phencyclidine, 
ketamine, and MK-801 (Fletcher et al., 2011; Mansbach and Geyer, 1991; Martinez et al., 2000), 
expanded on the PPI paradigm. Frontline pharmacological agents used in patients with 
schizophrenia, such as the typical antipsychotic haloperidol and the atypical antipsychotic 
clozapine, can restore in rats PPI deficits induced by apomorpine (Swerdlow, 1994). Together 
these studies suggest the involvement of monoamine neurotransmitter receptors in psychiatric 
‘gating’ disorders. Indeed, there is considerable target overlap, given drugs that modulate 
monoamine neurotransmitter system are used to treat psychotic, anxiety, and mood disorders. 
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While the clinical reality of using the PPI paradigm to predict antipsychotic efficacy is limited for 
those who need it, the involvement of forebrain monoamine and glutamate systems is clear. 
STUDYING EPIGENETICS BY CHROMATIN IMMUNOPRECIPITATION ASSAY OF HISTONE PTMS 
Chromatin immunoprecipitation (ChIP) is a useful biochemical assay in the study of 
epigenetic processes, especially in assessing distribution and relative abundance of target 
histone modifications and binding or occupancy of transcription factors and multi-protein 
complexes on DNA. Histone modifications can work in concert with DNA methylation to regulate 
cellular structure, function, and environmental exposure (i.e., drugs of abuse, early life stressors) 
(Cedar and Bergman, 2009). More than 130 unique histone modifications have been described 
to date, and chromatin immunoprecipitation allows for the exploration of their associations with 
the regulatory regions of target genes and other DNA/chromatin‐associated proteins across the 
genome (Strahl and Allis, 2000). Many variations of ChIP have been developed in the 30 years 
since its earliest version came into use, which makes it challenging for users to integrate the 
procedure into their research programs. Furthermore, differences between various protocols can 
confound efforts to increase reproducibility across studies. Hence, before setting out to test our 
hypothesis, we conducted pilot studies of ChIP parameters, including conditions of sonication, 
chromatin solubilization, and Protein A/G bead substrate. 
The steps of a basic ChIP protocol are depicted in Figure 5. Briefly, dissected tissue is 
treated with fixative to crosslink molecules in situ. Following lysis, crosslinked chromatin is 
released from nuclei and solubilized. Chromatin is subsequently sheared by sonication to produce 
fragments amenable to immunoprecipitation by antibodies selective for histone modifications. The 
chromatin-antibody complex—and the DNA associated to the histone modification—is retrieved 
by addition of beads and serially washed to eliminate non-specific interactions. 
Immunoprecipitated DNA is eluted, proteins are digested, and then crosslinks reversed. Purified 
DNA is isolated by phenol-chloroform extraction and ethanol precipitation. Finally, abundance of 
immunoprecipitated DNA is quantified by qPCR assay and normalized to input. 
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CHAPTER 2: MATERIALS AND METHODS 
ANIMALS 
A total of 39 male rats from 30 different litters of the National Institute of Health-
Heterogenous Stock (NIH-HS) strain were used. This strain was derived in 2004 from an outcross 
breeding strategy of eight inbred strains (MR/N, WN/N, WKY/N, M520/N, F344/N, ACI/N, 
BN/SSN, and BUF/N) (Hansen and Spuhler, 1984). A permanent colony of NIH-HS rats is 
maintained at the Medical Psychology Unit, Department of Psychiatry and Forensic Medicine, 
School of Medicine, Autonomous University of Barcelona). Rats used for experiments were 
screened by prepulse inhibition testing session, as described (Oliveras et al., 2015). Rats were 
housed in same-sex pairs under standard conditions (12 hr: 12 hr light/dark cycle; 22 ± 2˚C; 50-
70% humidity; food and water ad libitum) in Macrolon cages (50 × 25 × 14 cm). Rats were 
approximately four months old of age (mass: 320-400 g) at time of experimentation.  
PREPULSE INHIBITION (PPI) OF ACOUSTIC STARTLE REFLEX  
To segregate NIH-HS rats into low and high experimental groups, animals were 
individually assessed for PPI behavior in a sound-attenuated box (SR-Lab Startle Response 
System, San Diego Instruments, San Diego, USA) (Oliveras et al., 2015; Rio-Alamos et al., 2019). 
Within each box, rats were placed in a cylinder atop a platform rigged to a piezoelectric sensor to 
detect the acoustic startle response at 65, 70, 75, and 80 dB. Startle response was measured 
throughout the whole session. The PPI behavioral assessment was performed during the light 
cycle. Each startle session included the following: 
1) Habituation: 5 min 
2) Background noise of 55 dB + 10 single-pulses of 105 dB for 40 ms.  
3) 10 × of each block below (set of 6 randomized trials [a-c]) 
A) 1 × 55 dB background  
B) 1 × [55 dB background + 105 dB pulse for 40 ms] for baseline response 
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C) 1 × [55 dB background + 65/70/75/80 dB prepulse for 20 ms + 105 dB pulse for 
40 ms] 
4) 5 × [55 dB background + pulse of 105 dB for 40 ms] 
Startle response was measured throughout the whole session. Only measurements of startle 
response after 3B and 3C sessions were used to calculate the PPI response, as a percentage for 
each of four prepulse intensities. The arithmetic mean of each prepulse intensity was calculated 
and is represented by % PPItotal (hereinafter: PPI response). 
% PPI = 100 −  
mean response of 3C trials
mean response of 3B trials
 × 100  
% PPItotal =
Σ (% PPI )
4
 
MRNA EXTRACTION AND PURIFICATION  
Four weeks after segregation of NIH-HS rats by PPI response, animals were humanely 
euthanized per institutional guidelines. Separate tissues comprising frontal cortex and striatum 
coordinates were harvested, whereupon one hemisphere (~100 mg) was flash frozen in liquid 
nitrogen for RNA isolation (see directly below) and the other (~100 mg) crosslinked in 
formaldehyde for chromatin immunoprecipitation assays (see farther below). Tissues were stored 
at −80˚C in nitrogen phase until analyzed.  
RNA was extracted using the NucleoSpin® RNA/Protein kit (Macherey-Nagel; 740933) 
per manufacturer’s protocol. Briefly, tissue was homogenized and lysed in buffer containing 1% 
β-mercaptoethanol. Genomic DNA (gDNA) was removed from extracted total RNA by on-column 
digestion with RNase-free DNase I (Ambion; AM1907). RNA concentration was 
spectrophotometrically quantified by NanoDrop 2000c (Thermo Scientific). Quality was assessed 
by Bioanalyzer 2100 (Agilent Technologies). Two samples were excluded based on the following 
criteria: A260/A280 ratio less than 1.8 or RNA integrity number (RIN) value less than 5. RNA was 
stored at −80˚C until analysis by quantitative polymerase chain reaction (qPCR). 
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QPCR ANALYSIS OF MRNA EXPRESSION 
For gene expression analysis, qScript cDNA 5x SuperMix (Quanta; 95048) was used per 
manufacturer’s protocol. In brief, 200 ng purified mRNA were reverse transcribed into 
complementary DNA (cDNA) (25°C for 5 min; 42°C for 30 min; 85°C for 5 min; and stored at 4°C). 
cDNA products were diluted 1:4 in RNase/DNase-free water and kept at -20°C until the qPCR 
assay. Products were assayed in triplicate on a 96-well plate. Each reaction well contained the 
following components: appropriate primer sets, diluted cDNA, RNase/DNase-free water, and 2x 
Fast SYBR Green master mix (Applied Biosystems; 4385612). Each plate was run on the 
QuantStudio 3 Real-Time PCR System (Applied Biosystems; A28567) with optimized thermocycle 
profiles for each primer set. For sequences of RT-qPCR oligonucleotides, see Table 2. 
Gene targets Grm2, Drd1, Drd2, Htr1a, Htr2a, and Homer1 used the following thermocycle 
profile: 10 min at 95°C; 40 cycles of 15 s at 95°C (melt); 30 s at 60°C (anneal & extension). 
Reference genes Gapdh and Rpl13a used the following profile: 10 min at 95°C; 40 cycles of 15 s 
at 95°C (melt); 30 s at 60°C (anneal); 30 s at 72°C (extension), per manufacturer’s guidelines 
(Table 3). RNase/DNase-free water was substituted in place of diluted cDNA as a negative 
control. cDNA derived from Rat Universal Reference total RNA (Agilent Technologies; 740200) 
controlled for intraplate variance. Specific and on-target amplification was confirmed by the 
presence of a single sharp peak by melting curve analysis (Østerbøg TB et al., collaborator’s 
master’s thesis entitled “Gene expression profiles associated with sensorimotor gating response 
in the genetically heterogeneous NIH-HS rats” submitted January 28, 2018). Relative gene 
expression was calculated by the 2–∆∆Ct method (Livak and Schmittgen, 2001), normalizing first to 
the two reference genes, Gapdh and Rpl13a, then to experimental controls. Expression levels of 
housekeeping genes did not differ across groups.  
WESTERN BLOTTING 
We conducted pilot studies using magnetic and polyacrylamide beads due to limited tissue 
quantity and differences in binding capacity of these protein A/G resin substrates for 
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immunoprecipitation. Two or five g anti-H3K27me3 antibody were conjugated to polyacrylamide 
UltraLink Resin (Thermofisher Scientific; 53132) or magnetic beads (ThermoFisher Scientific; 
88802) for 16 hours at 4˚C on an end-over-end rotator. The antibody-bead complex (bound 
fraction) and the flow-through containing unbound antibody were collected for analysis by 
Western blot.  
Western blot experiments were performed as previously reported in (González-Maeso et 
al., 2008) with minor modifications. Briefly, samples were denatured in Laemmli sample buffer, 
resolved by SDS-PAGE, and transferred to nitrocellulose. Membranes were probed with 1:200 
dilution of primary antibody (anti-kappa light chain Ab, Novus Biologicals; NBP2-15191) followed 
by incubation with HRP-conjugated secondary antibody (Amersham Biosciences). Washes were 
conducted with TBS-T + 0.1% Tween-20. Immunoreactive proteins were visualized with 
enhanced chemiluminescence (ThermoScientific) on Odyssey infrared imaging system (LI-COR 
Biosciences) per manufacturer’s protocol. 
CHROMATIN CROSSLINKING  
Immediately after harvest of relevant brain tissues by collaborators at the University of 
Copenhagen, one hemisphere from a single animal was fixed in 1% formaldehyde at RT. After 20 
min, crosslinking was quenched by addition of concentrated glycine (Sigma; G8898) to a final 
concentration of 0.125 M for 5 min at RT. Samples were then centrifuged at 1,500 × g for 5 min 
at 4°C, and the supernatant containing flocculate masses was aspirated. The pellet containing 
fixed homogenates were resuspended in 1 mL PBS + 0.1% Protease Inhibitor Cocktail (Sigma; 
P8340) and transferred to a new tube and centrifuged as before. The supernatant was aspirated, 
and the pellets were immediately flash frozen and stored at −80°C until the ChIP assay. Fixed 
and frozen specimens were shipped to Virginia Commonwealth University in dry ice by 
collaborators. 
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OPTIMIZATION OF CHROMATIN SOLUBILIZATION AND FRAGMENTATION  
Ideal conditions for chromatin solubilization and fragmentation were determined to 
maximize qPCR signal. Tissue was subjected to lysis under conditions of (1) whole cell lysis or 
(2) hypotonic lysis followed by nuclear lysis. Treatment with SDS lysis buffer generates whole cell 
lysate, while hypotonic lysis buffer selectively ruptures the cytoplasmic membrane, yielding nuclei 
which are subsequently subjected to lysis. Approximately 100 mg of frozen and fixed tissues with 
hippocampal coordinates of NIH-HS animals were used to test DNA fragmentation conditions. 
The cell density of test tissue was similar to tissues used later in ChIP assays. To solubilize 
crosslinked chromatin, tissue was treated with SDS lysis buffer (50 mM Tris, 10 mM EDTA, 1% 
SDS), yielding whole cell lysate, or hypotonic lysis buffer (50 mM HEPES-KOH, pH 7.4, 140 mM 
NaCl, 1 mM EDTA, 10% glycerol, 0.5% IGEPAL CA-630 (Sigma-Aldrich; I-3021), and 0.25% 
Triton X-100 (Sigma-Aldrich; BP151)), yielding nuclei. Nuclei were rinsed with wash buffer 
containing 10 mM Tris-Cl, pH 8.1, 200 mM NaCl, 1 mM EDTA, and 0.5 mM EGTA, and then lysed 
in nuclear lysis buffer (10 mM Tris-Cl, pH 8.1, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% 
deoxycholate (Sigma-Aldrich; D-6750), and 0.5% N-lauroylsarcosine (Sigma-Aldrich; L-9150)).  
Chromatin was fragmented with a Q700 sonication system (QSonica; CL-334) with 
microtip attachment. The duration of sonication was determined, starting with 2 cycles at 10 
pulses (1 sec on and 1 sec off) for a total process time of 20 sec per cycle at 8% amplitude and 
increasing to 10 cycles. Each tube was incubated on ice for at least 90 sec between cycles to 
prevent premature de-crosslinking or denaturation of antibody epitope. Ten μL of fragmented 
chromatin was removed after each cycle. After fragmentation of DNA and clarification by high-
speed clarification at 16,000 × g for 15 min at 4˚C, 10 μL treated with 2 μL of 10 mg/mL Proteinase 
K (ThermoFisher; AM2546) at 55˚C for 2 hr followed by 1 μL of 20 mg/mL RNase A (Invitrogen; 
12091039) at 37˚C for 1 hr. Samples were incubated at 65˚C for at least 4 hr to reverse crosslinks. 
DNA was purified by phenol/chloroform/isoamyl alcohol extraction followed by ethanolic 
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precipitation. Purified samples were resolved electrophoretically on a 1.5% TAE (Tris base, acetic 
acid, and EDTA, pH 8.3) gel with Orange G loading dye (NEB; B7022S).  
CHROMATIN IMMUNOPRECIPITATION ASSAY 
Chromatin immunoprecipitation was performed as described with minor modification 
(McCullough et al., 2017). Pellets containing crosslinked histone proteins and DNA (chromatin) 
were fractionated to selectively lyse the cytoplasm and isolate intact nuclei. Nuclei were 
resuspended in ice-cold lysis buffer supplemented with Protease Inhibitor Cocktail II (Millipore; 
539132) and 100 mM PMSF (Sigma; P7626). Extracted chromatin was sonicated for 7 cycles, as 
described above. Following clarification by high-speed centrifugation at 16,000 × g for 15 min at 
4˚C, 20 μL of the supernatant containing sheared chromatin was collected and stored at 4˚C for 
input DNA. The remaining extract was prepared for immunoprecipitation with ChIP-grade 
antibodies specific for rabbit anti-H3K27me3 (2 g, Millipore; 07-449); rabbit anti-H3ac (5 g, 
Millipore; 06-599), or rabbit IgG (5 g, Millipore; 12-370). Antigen-antibody complexes were 
retrieved by co-addition of polyacrylamide A/G resin (ThermoFisher Scientific; 53132). After 16 
hours, the protein/DNA/resin complexes were collected by gentle centrifugation (1,000 × g for 1 
min). To remove non-specific interactions, samples were washed in a series of four ice-cold 
buffers (1 mL for 5 min at 4˚C on an end-over-end rotator for each): (1) low salt wash buffer (20 
mM Tris, pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), (2) high salt wash 
buffer (20 mM Tris, pH 8.1, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), (3) LiCl 
wash buffer (10 mM Tris, pH 8.1, 1 mM EDTA, 1% IGEPAL CA-630, 250 mM LiCl, 1% sodium 
deoxycholate), and (4) TE buffer (10 mM Tris, pH 8.5, 1 mM EDTA). Next, immunoprecipitated 
protein/DNA complexes were eluted from the resin. Immunoprecipitated genomic DNA and input 
samples were treated with proteinase K, DNase-free RNase A, and de-crosslinked by incubating 
at 65˚C for at least 4 hr. DNA was purified by phenol/chloroform extraction and precipitated, as 
described directly below. The precipitated DNA was resuspended in TE buffer and stored at −20˚C 
until qPCR analysis. 
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PRECIPITATION OF IMMUNOPRECIPITATED GDNA FRAGMENTS 
Following protein digestion, RNase treatment, and decrosslinking, immunoprecipitated 
gDNA was purified by phenol/chloroform/isoamyl alcohol (PCI) extraction (ThermoFisher; 
15593031) followed by ethanolic precipitation. One volume of PCI was added to the sample and 
thoroughly vortexed before centrifuging 3 min at 13,000 × g at room temperature. The upper 
aqueous layer was transferred to a new tube and back-extracted with an equal volume of freshly 
prepared 1:1 (v/v) chloroform/isoamyl alcohol solution. Following resolution of layers, the upper 
aqueous layer was transferred to a new tube. Forty-four μL of 3 M sodium acetate (pH 5.2), 2 μL 
of 20 mg/mL glycogen (Invitrogen; R0561), and 1 mL of 100% ethanol were added. This mixture 
was thoroughly vortexed and precipitated at −80°C overnight. The DNA was pelleted by high-
speed centrifugation (15,000 × g for 20 min at 4°C) and washed twice with 1 mL of 70% ethanol 
(chilled to −20°C). DNA pellets were dried and resuspended in TE buffer. To visualize sonicated 
chromatin, DNA was loaded with Orange G dye and resolved on a 1.5% agarose/TBE gel (Voytas, 
2000) stained with 0.4 μg/mL ethidium bromide alongside a DNA ladder. The gel was de-stained 
in TBE buffer, as necessary, and visualized on a UV transilluminator. 
QPCR ANALYSIS OF CHROMATIN IMMUNOPRECIPITATED GENOMIC DNA (CHIP-QPCR)  
Genomic abundance of chromatin immunoprecipitated DNA was assessed by qPCR with 
validated primer sets. Each reaction well contained the following components: 2 μL genomic DNA, 
200 nM primers, and 2X PowerUp SYBR® Green Master Mix (ThermoFisher; A25742) and was 
prepared in quadruplicate in a 384-well microplate. Each plate was run on the QuantStudio 6 Flex 
Real-Time PCR System (Applied Biosystems; 4485691) with the following thermocycle program: 
2 min at 50°C; 2 min at 95°C; 45 cycles of 15 s at 95°C and 1 min at 60°C. All primer sets displayed 
on-target specificity by melt curve analysis. Melt curve analysis was conducted (5 min of 60 to 
95°C at 0.05˚C/s, 15 s at 95°C) to verify on-target genomic amplification. Relative genomic 
abundance of histone modifications at target genomic loci was expressed as % of input, as based 
on a previous publication (Kurita et al., 2013). Briefly, Ct values of input DNA were corrected with 
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respect to the volume removed from the total immunoprecipitation volume. The Ct values 
corresponding to genomic targets were then calculated utilizing the 2–∆∆Ct method (Livak and 
Schmittgen, 2001) to obtain % of input values.  
Genome sequence for Rattus norvegicus were obtained from ENCODE (Davis et al., 
2018; ENCODE Project Consortium, 2012). ChIP-qPCR primers were designed for the genes 
Grm2, Htr1a, Htr2a, Drd2, and Homer1 at three upstream regions, including transcriptional start 
site (TSS), proximal promoter (up to 1 kb upstream of TSS), and distal promoter (approximately 
1.4 kb upstream of TSS). For Gapdh, only primers targeting the proximal promoter were designed. 
For sequences of ChIP-qPCR oligonucleotides, see 
Table 4. 
STATISTICAL METHODS 
Statistical analyses were performed with GraphPad Prism 8. Kruskal-Wallis test with post 
hoc Dunn’s multiple comparison test was conducted for analyzing the PPI response across the 
different groups. For the mRNA expression, a D’Agostino & Pearson Omnibus normality test 
indicated that some data were not normally distributed. Multiple t tests with Holm-Šidák’s post hoc 
correction was conducted. Outliers were identified and excluded by the ROUT method (Q=1%). 
A model was constructed by a multinomial logistic regression analysis with PPI response 
(dependent variable) and mRNA expression (independent variable). Models were constructed 
independently for each genomic region. Genes with significant contributions to statistical model 
were subjected to regression analysis for confirmation. Statistical significance of H3ac and 
H3K27me3 ChIP assays was assessed by Mann-Whitney U tests at promoter region of Gapdh or 
by two-way ANOVA with Šidák’s multiple comparison corrections at gene regions of all other 
genes. The level of significance was chosen at p = 0.05. Data are presented as mean ± s.e.m. 
For detailed statistical analyses in tabular form are presented in the Appendix. 
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CHAPTER 3: RESULTS 
SEGREGATION OF NIH-HS RATS INTO GROUPS BY PPI RESPONSE 
Column analysis was performed for 39 HS rats based on individual PPI response, or 
%PPI. Animals were subsequently segregated into three groups (Figure 2 and Table 5). For PPI 
response, rats scoring in the first quartile (n=10) and last quartile (n=10) were placed into low PPI 
and high PPI groups, respectively; rats in the interquartile range (n = 19) were placed in a medium 
PPI group. Two-way ANOVA of PPI responses of these groups showed a significant difference in 
the %PPI of each group for each of four prepulse stimulus intensities (65, 70, 75, 80 dB), as well 
as for total % PPI. After Dunn’s multiple comparisons test, significant differences between the low 
PPI and high PPI groups remained (Table 6).  
INCREASED MRNA EXPRESSION IN LOW PPI GROUP 
When comparing the relative mRNA expression between the extreme PPI groups for 
frontal cortex (Figure 3A), a statistically significant increase in Grm2, Drd2, Htr1a, and Homer1 
was observed in the low PPI group compared to the high PPI group. There were no differences 
in Drd1 and Htr2a mRNA levels. After correcting for multiple comparisons, differences were no 
longer significant. In striatum (Figure 3B), a statistically significant increase in relative mRNA 
levels of Drd2, Htr1a, and Htr2a was observed in the low PPI group, as compared to the high PPI 
group. There were no differences in mRNA levels of Grm2, Drd1, and Homer1. Following 
correction for multiple testing, only Drd2 maintained significance.  
REGRESSION ANALYSIS OF GENE EXPRESSION & PPI RESPONSE 
We conducted a multinomial logistic regression analysis of all genes, PPI groups, and 
brain regions to determine the extent to which mRNA expression may pattern PPI response. The 
resulting model indicated that mRNA expression predicted the clustering of HS animals into their 
corresponding PPI group ( 
Table 7). In testing mRNA expression of individual genes for goodness-of-fit, we found 
that Grm2 in the frontal cortex and Drd2 and Grm2 in the striatum contributed significantly to the 
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model. In focusing on these genes, we subsequently sought to confirm correlation between mRNA 
expression and PPI response in a linear regression analysis. There was a statistically significant 
linear relationship between PPI and Grm2 expression levels in the frontal cortex (F(1,32) = 9.5; 
R2 = 0.23; p = 0.0043; slope = − 0.051, std. error = 0.017) (Figure 4A) and Drd2 expression in the 
striatum (F(1,33) = 5.2; R2 = 0.14; p = 0.0286, slope = − 1.4, std. error = 0.60) (Figure 4B). However, 
no statistically significant linear relationship was seen between PPI and Grm2 expression in the 
striatum (F(1,36) = 2.3; R2 = 0.06; p = 0.1391). 
ADAPTATION OF CHROMATIN IMMUNOPRECIPITATION ASSAY 
Due to technical variability of the ChIP assay, pilot studies were undertaken to determine 
optimal conditions in rat brain tissue. We first set out to determine best technical conditions of the 
ChIP protocol in our hands, focusing on a few key steps of the assay which we have previously 
experienced as critical for success. The first of these studies looked into the most variable step 
of the ChIP protocol: sonication by ultrasound treatment. Sonication serves two main purposes: 
first in facilitating solubilization and second in shearing of chromatin into fragments tractable for 
immunoprecipitation and more reliable mapping of the target histone modification by qPCR. To 
determine how many cycles were necessary with our sonication setup, after successive 
sonication cycles small sample amounts were removed for analysis. Visualization of agarose-
resolved DNA fragments showed a cycle-dependent shift in the average electrophoretic mobility 
of fragments, with successive cycles producing a smaller average fragment size over a narrower 
range (Figure 6A). Based on reported guidelines, we determined that six sonication cycles were 
sufficient to yield the appropriate range of fragment sizes amenable for immunoprecipitation. 
The next preliminary study looked into buffer conditions into which chromatin is solubilized 
and then sonicated. To liberate crosslinked protein-DNA adducts, similar amounts of brain tissue 
were subjected to lysis by either whole cell or nuclear lysis after selective removal of cellular 
contents (e.g., plasma membrane components, cytoskeleton, cytoplasmic proteins and nucleic 
acids) under hypotonic conditions (hereinafter: nuclear lysis). Although both methods achieved 
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sufficient solubilization post-sonication, conditions of whole cell lysis yielded a higher apparent 
amount of soluble DNA over nuclear lysis (Figure 6B). Despite the difference in efficiency of 
solubilization, we chose to sonicate under nuclear lysis conditions because only the DNA-protein 
interactions within the nuclear compartment were of relevance in this study.  
We next compared the binding capacities of polyacrylamide resin and magnetic beads 
which are commonly used substrates to capture antibody-antigen complexes from solution in 
immunoprecipitation assays. To this end, either 2 or 5 g anti-H3K27me3 ChIP-grade antibody 
were conjugated to identical volumes of polyacrylamide resin or magnetic beads overnight. The 
flow-through, containing unbound antibody, and the bound fraction, containing the antibody-
substrate complex, were then subjected to polyacrylamide gel electrophoresis under denaturing 
conditions (SDS-PAGE) and probed with an anti-light chain antibody to assess the presence of 
anti-H3K27me3 antibody. After visualization, a single band with appreciable intensity was 
observed for each of the flow-through and bound fractions, suggesting both tested substrates 
captured the test antibody. Yet the polyacrylamide resin exhibited more complete, semi-
quantitative binding of the test antibody, as compared to the magnetic beads (Figure 6C). 
Saturation of magnetic beads occurred between 2 and 5 g of test antibody, as seen by 
corresponding bands of equal intensity in the bound fraction with the co-occurrence of a band in 
the flow-through fraction corresponding to 5 g. Bands were absent in polyacrylamide resin flow-
through for either amount of test antibody.  
Having determined working parameters for ChIP, we assessed in high and low PPI groups 
levels of the activating H3ac mark at the proximal gene promoter of Gapdh. We found relative 
enrichment of H3ac levels over background at its gene promoter, with ChIP signal for H3ac levels, 
on average, accounting for ~7% of input in the low PPI group and ~6% in high PPI group, a 
difference found to be insignificant (Figure 7A). We also assessed levels of a repressive histone 
mark using a ChIP validated antibody specific for H3K27me3 in parallel with IgG as a negative 
 - 24 - 
control. Between PPI groups, we detected low H3K27me3 levels at Gapdh, ~0.5% input for low 
PPI and ~0.4% input for high PPI (0.4% of input) groups, a statistically insignificant difference 
(Figure 7B). No qPCR signal was detected for IgG ChIP, validating the specificity of the binding 
to the H3K27me3 modification. 
CHROMATIN IP OF H3AC AND H3K27ME3 MARKS IN HIGH AND LOW PPI ANIMALS 
We next set out to determine by ChIP if patterns of H3ac and H3K27me3 was associated 
with mRNA expression of Grm2 in frontal cortex or Drd2 in striatum which were indicated to 
contribute significantly to PPI response. Two-way ANOVA of H3ac or H3K27me3 ChIP at Grm2 
gene regions in frontal cortex did not show significant differences between low and high PPI 
animals (Figure 8). There was a main effect of gene region at Grm2 on H3ac and H3K27me3 
levels, though post hoc analysis did not reveal significant effects (for statistics, see Table 10). 
Two-way ANOVA of H3ac or H3K27me3 ChIP at Drd2 gene regions in striatum did not show 
significant differences between low and high PPI animals (Figure 9). For H3ac, but not 
H3K27me3, there was a main effect of gene region, though post hoc analyses did not reveal 
significant effects on PPI response (Table 11). 
To investigate a link between histone modifications and gene expression, we also 
assessed levels of H3ac and H3K27me3 at other genes that we found upregulated in frontal 
cortex of the low PPI group but did not correlate with PPI response per se. Two-way ANOVA of 
H3ac ChIP at Drd2, Htr1a, Htr2a, and Homer1 gene regions did not show significant differences 
between low and high PPI animals (Figure 10), though an overall effect of gene region was noted 
for all tested targets. For H3K27me3 levels in the frontal cortex, a main effect of gene region was 
indicated for Drd2 and Homer1, but not Htr1a or Htr2a (Figure 11). Post hoc analyses did not 
reveal a significant effect of H3ac or H3K27me3 modifications on PPI response (Table 10).  
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CHAPTER 4: FIGURES 
 
FIGURE 1. CHROMATIN’S STRUCTURAL AND FUNCTIONAL UNIT IS THE NUCLEOSOME 
In eukaryotes, chromosomal DNA does not exist as a naked macromolecule. Instead it intertwines 
a core of highly basic histone proteins to form chromatin. This nucleoprotein complex collectively 
forms the structural and functional unit of chromatin called the nucleosome. Chromatin is then 
folded into higher-order structures, resulting in further genome compaction to fit inside the 
nucleus. The nucleosome consists of a histone core, an octameric assembly of two histone 
H2A/H2B dimers and a H3 and H4 tetramer. In addition, linker histone H1 binds regions of DNA 
on either side of a single nucleosome particle. Beyond a structural scaffold, more recently 
appreciated is that chromatin can regulate critical molecular functions via histone posttranslational 
modification of histones (e.g., acetylation, methylation, phosphorylation, etc.). By installation of 
histone posttranslational modifications, it is thought that molecular processes including gene 
transcription can be epigenetically controlled. Source image reproduced with permission from 
(Wang et al., 2017). 
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FIGURE 2. SEGREGATION OF NIH-HS RATS INTO DIFFERENT PPI GROUPS  
NIH-HS rats were subsequently segregated into three groups based on PPI response (% PPI). 
Rats in the first and last quartile for PPI response (n=10 rats each) were segregated into low PPI 
and high PPI groups, respectively. Remaining animals (n=19) were placed in a medium PPI 
group. Collaborators at University of Copenhagen produced this figure. Reproduced with 
permission from (Østerbøg et al., 2019). For descriptive statistics of PPI groups, see Table 5 and 
Table 6. 
  
Lo
w
M
ed
iu
m
H
ig
h
0
20
40
60
80
100
%
 P
P
I
 - 27 - 
 
FIGURE 3. MRNA EXPRESSION IN LOW AND HIGH PPI GROUPS 
A. mRNA expression of Grm2, Drd2, Htr1a, and Homer1 was significantly increased in low PPI 
animals in frontal cortex. Differences did not pass multiple testing correction. B. mRNA expression 
of Drd2, Htr1a, and Htr2a was significantly increased in low PPI animals in the striatum, n=8 rats. 
Data are presented as mean ± s.e.m. Statistical significance was set at p < 0.05. *p < 0.05, **p < 
0.001, #p < 0.05 after post hoc correction. Collaborators at University of Copenhagen produced 
this figure. Reproduced with permission from (Østerbøg et al., 2019). For t test statistics, see 
Table 8. 
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FIGURE 4. REGRESSION ANALYSIS BETWEEN PPI RESPONSE AND MRNA EXPRESSION  
Linear regression analysis of PPI response (dependent variable) and mRNA expression 
(independent variable). A. Grm2 expression levels in the frontal cortex correlate with PPI 
response (R2 = 0.23; p = 0.0043). B. Drd2 expression levels in the striatum correlate with total 
PPI response (R2 = 0.14; p = 0.0286). Statistical significance was set at p < 0.05. Filled circles 
represent low PPI, open circles medium PPI and open triangles high PPI animals. For linear 
regression analysis statistics, see  
Table 7. Collaborators at University of Copenhagen produced this figure. Reproduced with 
permission from (Østerbøg et al., 2019).  
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FIGURE 5. CHROMATIN IMMUNOPRECIPITATION PROTOCOL 
Dissected tissue is treated with fixative to crosslink molecules in situ. Following lysis, crosslinked 
chromatin is released from nuclei and solubilized. Chromatin is subsequently sheared by 
sonication to produce fragments amenable to immunoprecipitation by antibodies selective for 
histone modifications. The chromatin-antibody complex—and the DNA associated to the histone 
modification—is retrieved by addition of beads and serially washed to eliminate non-specific 
interactions. Immunoprecipitated DNA is eluted, proteins are digested, and then crosslinks 
reversed. Purified DNA is isolated by phenol-chloroform extraction and ethanolic precipitation. 
Finally, abundance of immunoprecipitated DNA is quantified by qPCR assay and normalized to 
input DNA. 
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FIGURE 6. PILOT STUDIES OF CHIP TECHNICAL PARAMETERS 
A. Representative DNA agarose gel showing effect of sonication cycle number on DNA fragment 
size. B. Representative DNA agarose gel showing resolution of sonicated DNA following whole 
cell lysis or hypotonic lysis. C. Western blot analysis with - chain antibody comparing binding 
capacity of Protein A/G-linked polyacrylamide (P) and magnetic (M) substrates. Flow-through 
(left) shows unbound antibody. Bound fraction (right) shows antibody eluted from resin. Number 
above image indicates g of ChIP antibody coupled to substrate. D. Schematic showing 
approximate genomic locations of ChIP-qPCR primer pairs for tested genes, as indicated below 
TSS, transcriptional start site. 
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FIGURE 7. H3AC AND H3K27ME3 LEVELS AT GAPDH PROMOTER 
In frontal cortex and striatum, levels of (A) H3ac and (B) H3K27me3 levels were not significantly 
different between low and high PPI groups. (A) H3ac, n=8-10 (B) H3K27me3 n=5-10. Statistical 
significance was set at p < 0.05. Data are presented as mean ± s.e.m. For Mann Whitney test 
statistics, see Table 9. 
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FIGURE 8. H3AC AND H3K27ME3 LEVELS AT REGIONS OF GRM2 IN FRONTAL CORTEX 
No significant difference in levels of (A) H3ac (n=5-6 rats) and (B) H3K27me3 (n=8-9 rats) at 
indicated Grm2 gene regions in frontal cortex of low and high PPI animals. Statistical significance 
was set at p < 0.05. Data are presented as mean ± s.e.m. For two-way ANOVA with Holm-Šidák’s 
multiple comparison test, see Table 10. 
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FIGURE 9. H3AC AND H3K27ME3 LEVELS AT REGIONS OF DRD2 IN STRIATUM 
No significant difference in levels of (A) H3ac (n=8 rats) and (B) H3K27me3 (n=5-6 rats) at 
indicated Drd2 gene regions in striatum of low and high PPI animals. Statistical significance was 
set at p < 0.05. Data are presented as mean ± s.e.m. For two-way ANOVA with Holm-Šidák’s 
multiple comparison test, see Table 11. 
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FIGURE 10. H3AC LEVELS AT REGIONS OF GENES IN FRONTAL CORTEX 
No significant difference in levels of H3ac at upstream locations of indicated genes in frontal cortex 
of low and high PPI animals. Statistical significance was set at p < 0.05. Htr1a, n=8; Htr2a, n=5-
6; Homer1, n=8 rats. Data are presented as mean ± s.e.m. For two-way ANOVA with Holm-
Šidák’s multiple comparison test, see Table 10. 
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FIGURE 11. H3K27ME3 LEVELS AT REGIONS OF GENES IN FRONTAL CORTEX 
No significant difference in levels of H3K27me3 at upstream locations of indicated genes in frontal 
cortex of low and high PPI animals. Statistical significance was set at p < 0.05. Htr1a, Htr2a, n=9; 
Homer1, n=5-6 rats. Data are presented as mean ± s.e.m. For two-way ANOVA with Holm-Šidák’s 
multiple comparison test, see Table 10. 
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CHAPTER 5. DISCUSSION 
Here we report no difference in levels of H3ac or H3K27me3 between PPI groups across 
three upstream regions of Grm2, Drd1, Drd2, Htr1a, Htr2a, and Homer1 of HS rats. The aim of 
the study was to assess in high and low PPI groups the relative abundance of two histone marks 
at DNA promoters of genes involved in sensorimotor gating regulation. We evaluated baseline 
levels of histone marks involved in gene transcription, namely activating H3ac and repressive 
H3K27me3. To this end, we adapted and validated a ChIP protocol for use in fixed frozen brain 
tissue.  
FEASIBILITY OF CHROMATIN IMMUNOPRECIPITATION IN FROZEN BRAIN TISSUE 
Before setting out to test our hypothesis, we determined ideal parameters for the 
chromatin immunoprecipitation, or ChIP, protocol using frozen brain samples in a series of pilot 
studies. One of the most critical elements of a successful ChIP protocol—shearing of DNA—is 
also its most variable (Pchelintsev et al., 2016). To achieve this end, fixed samples can be 
subjected either to enzymatic digestion with micrococcal nuclease (MNase) (Telford and Stewart, 
1989; Thorne et al., 2004) or to high-energy ultrasonic treatment. Both approaches have been 
used by our group successfully to shear DNA. Frozen tissues, such as post-mortem human brain, 
were unable to be sonically sheared and required MNase digestion to achieve appropriate DNA 
fragments (Kurita et al., 2012), and only freshly fixed, never frozen samples were amenable to 
the ChIP protocol. The use of ultrasonic treatment on frozen samples had yet to be addressed.  
The general consensus in the literature suggests that chromatin be shared to fragments 
within the range of 200 to 1,000 bp (Rodríguez-Ubreva and Ballestar, 2014). Larger chromatin 
fragments may reduce the selectivity, as detected signals may be from more distant nucleosomes 
linked to target loci, while smaller fragments hinder the detection at all (Lee et al., 2006). 
Sonication for ChIP requires consideration of numerous factors, including cell or tissue type, 
degree of crosslinking, buffer composition, as well as parameters of the instrument used for 
sonication, including means of energy dispersal, power output, and process duration. To 
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determine that DNA shearing yielded chromatin fragments amenable to immunoprecipitation, we 
set out to determine appropriate number of sonication cycles, including power output and time 
intervals between active ultrasound treatment. It is also noteworthy that as all polymeric 
macromolecules are subject to ultrasound-mediated shearing, samples at this stage comprise a 
crude mixture of fragments, requiring further processing (e.g., removal of insoluble debris, RNase 
and proteinase treatment, and crosslink reversal). Limited by starting tissue quantity, we opted to 
minimize loss by precipitating DNA following organic extraction instead of using spin-columns 
where an appreciable amount of sample can be lost on the silica matrix. 
We also focused on determining conditions that would solubilize sufficient chromatin from 
crosslinked tissues for subsequent fragmentation. Isolation of nuclei from tissues yielded a 
sufficient fraction of soluble chromatin post-sonication. Interestingly, we noted a relatively intense 
population of slow-migrating DNA species under nuclear lysis that was less apparent under whole 
cell lysis. The apparently higher amount of soluble DNA under the whole cell lysis conditions may 
be due to the presence of SDS, which is otherwise absent in the nuclear lysis buffer.  
We also determined that use of polyacrylamide resin was ideal for our samples. Based on 
our findings and in consideration of the limited amount of soluble chromatin available from nuclear 
lysis, we proceeded to use polyacrylamide resin with the higher amount of ChIP-grade antibody. 
These findings may be because polyacrylamide resin is porous and has a large surface-area-to-
volume ratio and therefore a high binding capacity. On the other hand, magnetic beads are 
nonporous, and, although they are smaller in diameter, may exhibit a lower binding capacity than 
polyacrylamide resin.  
To validate our ChIP protocol, we assessed abundance of H3ac and H3K27me3 levels at 
Gapdh. We observed relative enrichment of activating H3ac and scant levels of repressive 
H3K27me3 marks, relative to IgG background at the proximal promoter region of Gapdh. As a 
housekeeping gene, Gapdh is constitutively expressed and its gene promoter is expected to bear 
marks associated with active gene transcription, including lysine acetylation of H3. There remains 
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the possibility that patterns of H3ac and H3K27me3 found at Gapdh across two brain regions 
were spurious. The presence of pan-acetylated H3 or absence of H3K27me3 at one gene locus 
may be insufficient evidence our ChIP protocol is operational, though another study has 
previously reported similar patterns of histone PTMs at Gapdh (Fomsgaard et al., 2018). Further 
investigations into abundance of additional histone modifications, including specific acetylated 
lysine residues, like H3K9ac and or H3K27ac, as well as other repressive marks, like H3K9me3 
or H4K20me3, at other transcriptionally active loci, including Gapdh, are warranted. Unbiased 
approaches like deep sequencing of the epigenome may yet offer clarify in this case and at large.  
EPIGENETIC ALTERATIONS IN SYNAPTIC PLASTICITY GENES 
The ability to ‘gate’ irrelevant stimuli while also attending to those relevant is an important 
and subconscious process of the central nervous system. Impairments in sensorimotor gating are 
considered a clinical endophenotype shared across several diagnostic domains of 
neuropsychiatric conditions (Owens et al., 2011). Deficits in this protective cognitive process are 
operationally defined by deficits in the prepulse inhibition of acoustic startle. Various approaches, 
including behavioral animal models, pharmacological dissection, and gene linkage and genome 
wide association studies have identified key neurobiological substrates regulating PPI, for 
instance, revealing a role for monoamine neurotransmitter receptors, as well as synaptic and 
neural plasticity genes in neurocircuits encompassing forebrain and midbrain structures. Despite 
steady contributions made over decades to understand the neurobiology of prepulse inhibition, 
viable therapeutic strategies from the bench did not translate to the clinic. With its polygenic 
inheritance pattern, variable phenotypic expressivity, and distributed neuroanatomical circuit, 
efforts to dissect the molecular mechanism of sensorimotor gating have remained elusive to date. 
Ample evidence has shown monoamine neurotransmitter systems are involved in the 
regulation of sensorimotor gating. The gene products of Drd1, Drd2, Htr1a, Htr2a, and Grm2 are 
psychotropic drug targets. It is also noteworthy that the neurobiology of the PPI response has 
been dissected with pharmacological agents targeting neurotransmitter systems studied here, as 
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with Grm2 (Bellesi and Conti, 2010; van Berckel et al., 2006) and Htr1a (Conti, 2012). Given that 
receptor mRNA is separable from consequent behavior-associated functions, it is possible that 
events beyond post-transcriptional regulation by histone PTMs plays a more direct mediating role 
in PPI response which is subject to processes of synaptic plasticity. For instance, the Homer1 
gene product regulates the functional assembly of post-synaptic density proteins at glutamatergic 
synapses to influence synaptic plasticity. Animals that lack Homer1 exhibit schizophrenia-like 
behaviors, including diminished PPI response (Datko et al., 2017). As a behavioral phenotype 
with translational value, if the PPI paradigm is in part epigenetically regulated, understanding the 
relationship between gene expression and histone modification can provide insight into the 
pathophysiology of other CNS disorders with deficits in inhibitory control processes.  
In RHA rats, a putative model of PPI deficiency, higher H3K27me3 levels at the Htr2a 
gene promoter in the striatum was correlated with decreased Htr2a mRNA (Fomsgaard et al., 
2018). This raised the possibility that baseline differences in histone modification are associated 
with altered gene expression relevant to PPI response. The present study in genetically distinct 
animals however was underpowered for robust regression analysis. Future studies using 
genetically diverse models are warranted to address a role for interindividual differences 
mediating the PPI response. 
Rationalized therapeutic insights into a complex, polygenic trait like PPI deficiency using 
highly inbred animal models may be circumscribed by a diminished pool of allelic variation 
stemming from many generations of inbreeding, drift, and fixation. Like other complex psychiatric 
conditions (Pierce et al., 2018; Ponomarev et al., 2012), PPI response is likely regulated by a 
number of genes and gene networks, including those tested here. To address this limitation, we 
used rats from a genetically heterogeneous stock. The HS model has been used to fine-map 
complex traits of numerous conditions, ranging from diabetes and heart disease to anxiety and 
drug abuse behaviors (Baud et al., 2013). This outbred stock features animals that bear a high 
degree of genetic mosaicism and manifest the breadth of phenotypic traits, notably including PPI 
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response explored here. More studies conducted will be needed to determine modifiable trait loci 
in phenotypically diverse populations and the epigenetic modifications regulating them. Moreover, 
genetic findings offer clues as to which molecular networks undergird associations to the impaired 
PPI response, thus expanding the molecular drug target space for exploration in drug discovery. 
Coupled with a reverse genetic approach, like Crispr-Cas9-mediated gene-editing, HS animals 
can be a yet more powerful model to further pinpoint the genetic and epigenetic correlates of 
complex behaviors in rats that may have translational relevance to neuropsychiatric conditions in 
humans.  
These findings also do not exclude the involvement of other genes in histone PTMs in 
transcriptional regulation of tested genes. We focused on frontal cortex and striatum, two forebrain 
structures that have been shown to regulate the PPI response. These findings suggest that 
neither histone modification within the frontal cortex and striatum contributes to the difference in 
PPI response. Studies looking at other regions like the hippocampus may be worthwhile. 
Furthermore, additional studies looking at other gene targets are warranted. Clinical studies of 
PPI dysfunction have implicated certain gene variants that can impact the course and severity of 
dysfunction via influences on neurotransmitter systems, neurocircuitry, cellular physiology, 
neurodevelopment, and other traits that culminate in appropriate behaviors. Other mechanisms, 
such as epigenetic regulation by DNA methylation or microRNAs, may be operable. We present 
these negative findings to underscore the importance of further investigations into epigenetic 
mechanisms that may offer insight into potential molecular pathways contributing to baseline 
patterns of gene expression of complex behaviors, including PPI.  
The notion that the epigenome is druggable is feasible and has been explored. For over 
thirty years now, azacytidine has been used in the treatment of hematologic malignancies. It was 
thought that as an inhibitor of DNA methyltransferase, azacytidine exerted its anti-tumor effect by 
thwarting the epigenetic process of post-replicative DNA methylation, thereby triggering DNA 
damage pathways. More recent studies have revealed a parallel mechanism of action, whereby 
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an intrinsic toxic antiviral response is elicited via transcriptional activation of endogenous retroviral 
sequences (Licht, 2015). Another case of an epigenetic target was also originally developed 
against hematologic malignancies and targets histone deacetylase complexes. These and other 
enzymes that reversibly modify the chromatin landscape are enticing drug targets. Inhibitors of 
HDACs have shown therapeutic promise in neurological and neurodegenerative disorders, like 
Alzheimer’s, Huntington’s, and Parkinson’s disease (Dietz and Casaccia, 2010; Penney and Tsai, 
2014), although not without risks of side effects. Given the intricate and interconnected molecular 
architecture of neuropsychiatric conditions (Gandal et al., 2018; Gratten et al., 2014), an unknown 
number of genes are likely contributing to the PPI response. Epigenomic profiling by ChIP 
sequencing may reveal distinct disease signatures to narrow the search window of the disease-
relevant genetic substrates. At present, however, targeted manipulation of particular histone 
PTMs as a therapeutic modality remains an aspirational and distant prospect. Concerted efforts 
will be needed to more fully characterize how chromatin-templated processes acting ‘above the 
genes’ interact with the genes themselves, ultimately to manifest as a phenotype with 
consequential health effects. Novel therapeutic rationales for wide-ranging disorders including 
neuropsychiatric conditions may lie in wait amidst the dynamic and complex landscape of the 
epigenome. 
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APPENDIX 
TABLE 2. RT-QPCR OLIGONUCLEOTIDE SEQUENCES (RATTUS NORVEGICUS) 
TABLE 3. RECOMMENDED THERMOCYCLE PROFILES FOR RT-QPCR  
Standard Cycling Mode (Primer Tm ≥60°C) 
Step Temp Duration Cycles 
UDG Activation 50˚C 2 min Hold 
AmpliTag® DNA 
Polymerase 
95˚C 2 min Hold 
Denature 95˚C 15 sec 
40 
Anneal/Extend 60˚C 1 min 
 
Standard Cycling Mode (Primer Tm < 60°C) 
Step Temp Duration Cycles 
UDG Activation 50˚C 2 min Hold 
AmpliTag® DNA 
Polymerase 
95˚C 2 min Hold 
Denature 95˚C 15 sec 40 
Gene 
(Accession ID) 
DNA Sequence (5’ to 3’) 
Gapdh 
(NM_017008.4) 
F: CATCAAGAAGGTGGTGAAGCA 
R: CTGTTGAAGTCACAGGAGACA 
Rpl13a 
(NM_173340.2) 
F: AGCAGCTCTTGAGGCTAAGG 
R: GGGTTCACACCAAGAGTCCA 
Grm2 
(NM_001105711.1) 
F: GTGGTGACATTGCGCTGTAA 
R: GCGATGAGGAGCACATTGTA 
Drd1 
(NM_012546.2) 
F: GGAGGACACCGAGGATGA 
R: ATGAGGGACGATGAAATGG 
Drd2 
(NM_012547.1) 
F: TCGAGCTTTCAGAGCCAACC 
R: GGGTACAGTTGCCCTTGAGTG 
Htr1a 
(NM_012585.1) 
F: CCAAGAAGAGCCTGAACGGA 
R: CTGCCTCACTGCCCCATTAG 
Htr2a 
(NM_017254.1) 
F: CCGCTTCAACTCCAGAACCA 
R: GATTGGCATGGATATACCTACAGA 
Homer1 
(AJ276327.1) 
F: CACCCGATGTGACACAGAACTC 
R: TGATTGCTGAATTGAATGTGTACCT 
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Anneal 55-60˚C 15 sec 
Extend 72˚C 1 min 
Reproduced from page 18 of https://assets.thermofisher.com/TFS-
Assets/LSG/manuals/4472919_4473367_SYBR_Select_MasterMix_UG.pdf 
TABLE 4. CHIP-QPCR OLIGONUCLEOTIDE SEQUENCES (RATTUS NORVEGICUS) 
Gene 
(Accession ID) 
DNA Sequence (5’ to 3’) Location 
Grm2 
(NC_005107.4) 
F: GGCAGAGCTGGATCTGGAAG 
Distal promoter 
R: AATGGGAGACAAGGTGGCAG 
F: ATTCAGCACCACAAGGTGGACA 
Proximal promoter 
R: CAATTTGGCCTGCACCTCTCGC 
F: ATGAGCACCGAGGCATACAG 
TSS 
R: GATGCGGTCCAGTGCAAAAA 
Htr1a 
(NC_005101.4) 
F: CGGGTGCTGAACCAAATTTCA 
Distal promoter 
R: TTGGTGGCATCCCTTGTCTT 
F: CTTCGCCCGAGCAAGTAAGA 
Proximal promoter 
R: TTCAGAGGGAGGGGATCCAG 
F: TCCACTTTCGGCGCTTTCTA 
TSS 
R: TGACAGTCTTGCGGATTCGG 
Htr2a 
(NC_005114.4) 
F: ACTGGTGTGGGCTAGAAGTGC 
Distal promoter 
R: GAGGGGCGAAGTGTGAGAAAA 
F: ACACGTTTGTGTCCCCGAAT 
Proximal promoter 
R: AACATGTGTGGCTCCTCTGG 
F: TTCGGAAGCATCGAACTGGA 
TSS 
R: AGAATGGAGAGGGCATGTCGG 
Drd2 
(NC_005107.4) 
F: ACATCTACAACTGGCAAGGGA 
Distal promoter 
R: GTTTTCCACCCAGTCGTGTG 
F: AGTGCTTCAGCTAGCCCTTG 
Proximal promoter 
R: GGGGAAGGAACCTTGAGAGC 
F: TGTACAAGGGGCGGGGTT 
TSS 
R: CACAAGAGGGGACCAGCC 
Homer1 
(NC_005101.4) 
F: GAGTAACCTGGCTGCTTGAGT 
Distal promoter 
R: GTTGCGCGGAGAATATAGCAC 
F: TTAGCCCAAAGGCCGAGTAA 
Proximal promoter 
R: GCTGATCATTTCGCTCACGTC 
F: AGCGAGAGAAACCAGAGCAG 
TSS 
R: CGGCCGGAAGTACTGCTAAA 
Gapdh 
(NC_005103.4) 
F: AACCCTCATCCGGTCACTTCC 
Proximal promoter 
R: CGAGTAGCTGGGCCTCTCTCA 
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TABLE 5. COLUMN STATISTICS OF PPI RESPONSE OF PPI GROUPS  
PPI Group n Minimum 1st Quartile Median 3rd Quartile Maximum 
Low 10 9.39 38.58 43.85 46.27 47.8 
Medium 19 48.71 50.7 57.43 67.38 70.71 
High 10 71.46 72.02 74.46 81.27 88.92 
TABLE 6. PPI RESPONSE OF PPI GROUPS TO DIFFERENT PREPULSE INTENSITIES 
Stimulus Low PPI Medium PPI High PPI 
Kruskal-
Wallis H 
p value 
Baseline* 369.0 ± 75.33# 775.80 ± 217.80 981.90 ± 193.10 6.981 0.0305 
%PPI65 dB**** 8.66 ± 10.57#### 42.55 ± 2.81 70.94 ± 3.01 28.36 < 0.0001 
%PPI70 dB**** 41.48 ± 4.38#### 53.63 ± 2.90 76.07 ± 2.52 22.20 < 0.0001 
%PPI75 dB**** 51.07 ± 3.30#### 66.55 ± 2.13 77.36 ± 2.73 18.82 < 0.0001 
%PPI80 dB*** 57.71 ± 4.77### 73.20 ± 3.15 82.91 ± 1.52 16.69 < 0.0001 
%PPItotal**** 39.73 ± 3.63#### 59.98 ± 1.82 76.82 ± 1.98 32.35 < 0.0001 
Kruskal-Wallis test with post hoc Dunn’s multiple comparison test. %PPItotal represents mean % 
PPI score for different prepulse intensities. (*)Asterisk denotes significant difference in PPI 
response across the three groups. # denotes significant difference between low and high of PPI 
groups following post hoc analysis. Low PPI, n=10; medium PPI, n=19; high PPI, n=10 rats. Data 
is presented as mean ± s.e.m. Statistical significance was set at p < 0.05. *p ≤ 0.05 ***p ≤ 0.001, 
****p < 0.0001, #p ≤ 0.05, ###p ≤ 0.001, ####p < 0.0001 (after Dunn’s post hoc correction) 
TABLE 7. MULTINOMIAL LOGISTIC REGRESSION ANALYSIS OF PPI RESPONSE & MRNA LEVELS 
Brain Region Gene 
-2 log likelihood of reduced 
model 
Likelihood ratio tests 
χ2 df p value 
Frontal cortex 
Grm2 48.047 8.239 2 0.016 
Htr1a 42.722 2.915 2 0.233 
Htr2a 40.288 0.481 2 0.786 
Drd1 44.292 4.485 2 0.106 
Drd2 43.291 3.483 2 0.175 
Homer1 42.288 2.480 2 0.289 
Striatum 
Grm2 49.154 7.722 2 0.021 
Htr1a 46.294 4.862 2 0.088 
Htr2a 41.917 0.486 2 0.784 
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Drd1 45.545 4.113 2 0.128 
Drd2 57.260 15.829 2 0.000 
Homer1 45.519 4.087 2 0.130 
TABLE 8. MULTIPLE T TESTS WITH HOLM-ŠIDÁK’S MULTIPLE CORRECTIONS: GENE EXPRESSION 
Brain Region Gene p value Adj. p value 
Frontal cortex 
Grm2 0.0771 0.2140 
Drd1 0.8659 0.9820 
Drd2 0.0062 0.0365 
Htr1a 0.0340 0.1590 
Htr2a 0.0360 0.1590 
Homer1 0.8965 0.9820 
Striatum 
Grm2 0.0368 0.1173 
Drd1 0.0802 0.1540 
Drd2 0.0299 0.1173 
Htr1a 0.0246 0.1173 
Htr2a 0.0882 0.1540 
Homer1 0.0122 0.0711 
TABLE 9. MANN-WHITNEY TESTS OF H3AC AND H3K27ME3 CHIP (GAPDH PROMOTER) 
Brain Region Histone Mark Mann-Whitney U p value 
Frontal cortex 
H3ac 33 0.2176 
H3K27me3 33 0.2103 
Striatum 
H3ac 30 0.6058 
H3K27me3 10 0.4286 
TABLE 10. TWO-WAY ANOVA OF H3AC AND H3K27ME3 CHIP IN FRONTAL CORTEX 
Histone 
Mark 
Gene Variation F(dfn, dfd) p value 
 Holm-Šídák post hoc 
 
Gene Region 
Adj p 
value 
H3ac 
Grm2 
Interaction F(2,46) = 0.171  0.8435  -1.4kb  0.9029 
Gene region F(2,46) = 6.600  0.0030  Promoter  0.9881 
PPI F(1,46) = 0.182  0.6716  TSS  0.9965 
Drd2 
Interaction F(2,42) = 0.2950  0.7461  -1.4kb > 0.9999 
Gene region F(2,42) = 23.81 < 0.0001  Promoter  0.9684 
PPI F(1,42) = 0.0166  0.8981  TSS  0.8837 
Htr1a Interaction F(2,42) = 0.491  0.6153  -1.4kb  0.9948 
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Gene region F(2,42) = 13.20 < 0.0001  Promoter  0.8853 
PPI F(1,42) = 2.035  0.1611  TSS  0.3157 
Htr2a 
Interaction F(2,28) = 0.080  0.9237  -1.4kb  0.8861 
Gene region F(2,28) = 4.841  0.0156  Promoter  0.9799 
PPI F(1,28) = 1.190  0.2846  TSS  0.7813 
Homer1 
Interaction F(2,42) = 0.311  0.7341  -1.4kb  0.4550 
Gene region F(2,42) = 12.35 < 0.0001  Promoter  0.9893 
PPI F(1,42) = 1.589  0.2145  TSS  0.9293 
H3K27me3 
Grm2 
Interaction F(2,27) = 0.474  0.6275  -1.4kb  0.9937 
Gene region F(2,27) = 17.43 < 0.0001  Promoter > 0.9999 
PPI F(1,27) = 0.250  0.6208  TSS  0.6491 
Drd2 
Interaction F(2,27) = 0.332  0.7204  -1.4kb  0.9114 
Gene region F(2,27) = 6.495  0.0050  Promoter  0.6290 
PPI F(1,27) = 0.905  0.3499  TSS > 0.9999 
Htr1a 
Interaction F(2,24) = 0.180  0.8361  -1.4kb  0.9239 
Gene region F(2,24) = 3.330  0.0529  Promoter  0.4275 
PPI F(1,24) = 2.967  0.0978  TSS  0.6948 
Htr2a 
Interaction F(2,24) = 0.043  0.9581  -1.4kb  0.8903 
Gene region F(2,24) = 0.904  0.4184  Promoter  0.6567 
PPI F(1,24) = 2.098  0.1604  TSS  0.8173 
Homer1 
Interaction F(2,27) = 0.174  0.8414  -1.4kb  0.4242 
Gene region F(2,27) = 23.83 < 0.0001  Promoter  0.8426 
PPI F(1,27) = 2.643  0.1156  TSS  0.8903 
TABLE 11. TWO-WAY ANOVA OF H3AC AND H3K27ME3 CHIP IN STRIATUM (DRD2) 
Histone Mark Variation F(dfn, dfd) p value 
 Holm-Šídak post hoc 
Gene Region 
Adj p 
value 
H3ac 
Interaction F(2,51) = 0.1901  0.827  -1.4kb  0.929 
Gene region F(2,51) = 85.55 < 0.0001  Promoter  0.9529 
PPI F(1,51) = 1.751  0.192  TSS  0.4911 
H3K27me3 
Interaction F(2,53) = 1.540  0.224  -1.4kb  0.7248 
Gene region F(2,53) = 1.372  0.262  Promoter  0.8097 
PPI F(1,53) = 0.985  0.326  TSS  0.2992 
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